- Home
- RXT vs HUMA Comparison
RXT vs HUMA Comparison
Compare RXT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXT
- HUMA
- Stock Information
- Founded
- RXT 1998
- HUMA 2004
- Country
- RXT United States
- HUMA United States
- Employees
- RXT N/A
- HUMA N/A
- Industry
- RXT EDP Services
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- RXT Technology
- HUMA Health Care
- Exchange
- RXT Nasdaq
- HUMA Nasdaq
- Market Cap
- RXT 322.8M
- HUMA 367.6M
- IPO Year
- RXT 2020
- HUMA N/A
- Fundamental
- Price
- RXT $1.27
- HUMA $2.22
- Analyst Decision
- RXT Hold
- HUMA Strong Buy
- Analyst Count
- RXT 4
- HUMA 7
- Target Price
- RXT $1.63
- HUMA $13.00
- AVG Volume (30 Days)
- RXT 1.2M
- HUMA 3.5M
- Earning Date
- RXT 08-07-2025
- HUMA 08-12-2025
- Dividend Yield
- RXT N/A
- HUMA N/A
- EPS Growth
- RXT N/A
- HUMA N/A
- EPS
- RXT N/A
- HUMA N/A
- Revenue
- RXT $2,711,700,000.00
- HUMA $517,000.00
- Revenue This Year
- RXT N/A
- HUMA N/A
- Revenue Next Year
- RXT $1.48
- HUMA $896.45
- P/E Ratio
- RXT N/A
- HUMA N/A
- Revenue Growth
- RXT N/A
- HUMA N/A
- 52 Week Low
- RXT $1.00
- HUMA $1.15
- 52 Week High
- RXT $3.41
- HUMA $9.79
- Technical
- Relative Strength Index (RSI)
- RXT 50.93
- HUMA 45.56
- Support Level
- RXT $1.16
- HUMA $2.13
- Resistance Level
- RXT $1.30
- HUMA $2.30
- Average True Range (ATR)
- RXT 0.10
- HUMA 0.16
- MACD
- RXT 0.01
- HUMA -0.06
- Stochastic Oscillator
- RXT 37.90
- HUMA 16.47
About RXT Rackspace Technology Inc.
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.